U.S.

Veterans Affairs has provided few answers around coronavirus study, advocates say

Veterans Affairs has provided few answers around coronavirus study, advocates say

As per the veteran advocates, they are thwarted due to the absence of transparency that has been seen around the Veteran Affairs Department. This issue talks about how the department has been using hydroxychloroquine, a drug with skeptical proof, for coronavirus cure.

Post the disclosure of the study that involved veterans that were hospitalized after being diagnosed with coronavirus, it was confirmed that this drug had almost zero benefits in terms of treatment for COVID-19. Not just that, this drug was reported to have caused a higher number of deaths during the treatment phase.

Jeremy Butler, the CEO of Afghanistan and Iraq Veterans of the United States, mentioned that these results obtained from the study are seriously troubling for multiple reasons. This is why; the VA had to provide some answers.

In his statement, he also enquired why the veterans were receiving a doubtful treatment that came from a speculative and unproven drug. He also enquired if there was any approval process that came into use during the treatment agreement from doctors, patients, or their families.

This study was inclusive of results obtained from 368 different patients & is now among the largest known examination conveying the effects of this drug on the patients with COVID-19 positive status.

mm

Adam is a science graduate and professional with a strong experience in content management of Science related articles as well as headlines from the U.S.. Adam's strength includes the sound knowledge of science as well as astronomy.

About the author

mm

Adam Connelly

Adam is a science graduate and professional with a strong experience in content management of Science related articles as well as headlines from the U.S.. Adam's strength includes the sound knowledge of science as well as astronomy.

Add Comment

Click here to post a comment

Your email address will not be published. Required fields are marked *